219A Heartseed
- 2868
- +119+4.33%
Heartseed News
Heartseed: Notice regarding changes in the fiscal period (the last day of the fiscal year) and partial changes to the Articles of Incorporation
Heartseed: [Delayed]Financial Results for the Fiscal Year Ended October 31, 2024 (Under Japan GAAP)(Non-consolidated)
Heartseed: Notice Regarding the LAPiS Study Progress
Heartseed: Notice regarding the progress of the HS-001 LAPIS test
Heartseed: Notice Regarding the Revisions of Full-Year Financial Results Forecast for the Fiscal Year Ending October 31, 2024
Heartseed: Notice of completion of safety evaluation committee review on administration of HS-001 LAPIS test high dose group first case
Heartseed: [Delayed] Financial Results for the Nine Months Ended July 31, 2024 (Under Japan GAAP)(Non-consolidated)
Heartseed: Independent Company Executives Declaration
Heartseed: Articles of Incorporation 2024/04/17
Heartseed: Heartseed announced a positive recommendation from the safety monitoring committee regarding dose escalation in Phase 1/2 clinical trials administered with HS-001.
Heartseed: In the HS-001 LAPiS trial, the Safety Evaluation Committee recommended the start of administration in the high-dose group.
Heartseed: Matters related to business plans and growth potential.
Heartseed: Announcements of individual stocks regarding our financial information etc. due to our listing on the Tokyo Stock Exchange Growth Market.
Heartseed Inc.: Confirmation letter regarding the appropriateness of securities reports for listing application.
Heartseed Inc.: Quarterly report for IPO application (Q2)
Heartseed Inc.: Quarterly report for initial public offering (Q1)
Heartseed Inc.: Securities Report for Listing Application
No Data